PMH7 OUTCOMES AND COST OF TREATMENT WITH RISPERIDONE VERSUS OLANZAPINE AMONG PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)61073-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61073-X/fulltext
Section Title :
Section Order :
261
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61073-X&doi=10.1016/S1098-3015(10)61073-X